The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
A Longitudinal Study of Genital Human Papillomavirus Infection in a Cohort of Closely Followed Adolescent Women
Open accessAbstract
BACKGROUND: We performed a study to better characterize the natural history of genital human papillomavirus (HPV) infection in a cohort of closely followed adolescent women. METHODS: A cohort of 60 adolescent women was followed over a 2.2-year period, on average. A median of 41.5 self-collected vaginal and clinician-obtained cervical swabs were obtained from each subject. RESULTS: HPV was detected in 45.3% of all adequate specimens, by use of a polymerase chain reaction/reverse blot strip assay. Oncogenic--or high-risk (HR)--HPV types were detected in 38.6% of specimens, and nononcogenic--or low-risk (LR)--types were detected in 19.6% of specimens. During the entire study period, 49 of 60 subjects tested positive for HPV (cumulative prevalence, 81.7%). The most frequently detected HR types were HPV types 52, 16, and 59. Infections with multiple HPV types were common. The median duration of persistence of a specific HPV type was 168 days, and HR types were more persistent than LR types. Abnormal cervical cytological results occurred in 37% of the adolescent women and were significantly associated with HR HPV infection. CONCLUSIONS: The cumulative prevalence of HPV infection in sexually active adolescent women is extremely high, involves numerous HPV types, and frequently results in cervical dysplasia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674 · cited 1×
“To formally test the effect of the HPV types on the viral persistence (run length), we used a Cox proportional hazard model with random subject effect (also known as the “frailty model”); the random subject effect was introduced to accommodate the correlations among the runs contributed by the same subject [9].”
MethodNatural History of Cervicovaginal Papillomavirus Infection in Young Women
Ho, G. Y. F., Bierman, R., Beardsley, L., Chang, C. J., & Burk, R. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380703 · Cited by 2,329
Sexually transmitted disease surveillance
O'Connor, B. H., Tillett, H., Berrie, J. R. H., Emslie, J. A. N., & Adler, M. W. (1982) · BMJ · doi:10.1136/bmj.284.6318.825-d · Cited by 2,185
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,890
Sexually transmitted disease surveillance.
Schofield, C. B. (1982) · BMJ · doi:10.1136/bmj.284.6318.825-c · Cited by 1,869
Improved Amplification of Genital Human Papillomaviruses
Gravitt, P. E., Peyton, C. L., Alessi, T. Q., Wheeler, C. M., Coutlée, F., Hildesheim, A., Schiffman, M. H., Scott, D. R., & Apple, R. J. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.1.357-361.2000 · Cited by 1,137
Epidemiology of Genital Human Papillomavirus Infection
Koutsky, P. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00177-0 · Cited by 1,107
Sexually transmitted disease surveillance 2017
National Center for HIV/AIDS, V. H., Braxton, J., Davis, D. W., Emerson, B., Flagg, E. W., Grey, J., Grier, L., Harvey, A., Kidd, S., Kim, J., et al. (2018) · doi:10.15620/cdc.59237 · Cited by 1,026
Viral Infections of Humans. Epidemiology and Control.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-2-273_2 · Cited by 749
EPIDEMIOLOGY OF GENITAL HUMAN PAPILLOMAVIRUS INFECTION
KOUTSKY, L. A., GALLOWAY, D. A., & HOLMES, K. K. (1988) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036020 · Cited by 711
Cited by
The natural history of cervical HPV infection: unresolved issues
Woodman, C. B. J., Collins, S. I., & Young, L. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2050 · Cited by 1,033
The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States
Chesson, H. W., Dunne, E. F., Hariri, S., & Markowitz, L. E. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000193 · Cited by 706
Lehtinen, M., Paavonen, J., Wheeler, C. M., Jaisamrarn, U., Garland, S. M., Castellsagué, X., Skinner, S. R., Apter, D., Naud, P., Salmerón, J., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70286-8 · Cited by 704
The epidemiology of genital human papillomavirus infection
Trottier, H., & Franco, E. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.054 · Cited by 686
Immune responses to human papillomavirus
Stanley, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.002 · Cited by 586
Rapid Clearance of Human Papillomavirus and Implications for Clinical Focus on Persistent Infections
Rodriguez, A. C., Schiffman, M., Herrero, R., Wacholder, S., Hildesheim, A., Castle, P. E., Solomon, D., Burk, R., & On behalf of the Proyecto Epidemiologico Guanacaste Group (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn044 · Cited by 549
Garland, S. M., Steben, M., Sings, H. L., James, M., Lu, S., Railkar, R., Barr, E., Haupt, R. M., & Joura, E. A. (2009) · The Journal of Infectious Diseases · doi:10.1086/597071 · Cited by 532
Saslow, D., Castle, P. E., Cox, J. T., Davey, D. D., Einstein, M. H., Ferris, D. G., Goldie, S. J., Harper, D. M., Kinney, W., Moscicki, A.-B., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.7 · Cited by 521
Chapter 5: Updating the natural history of HPV and anogenital cancer
Moscicki, A.-B., Schiffman, M., Kjaer, S., & Villa, L. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.018 · Cited by 478
Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection
Brotman, R. M., Shardell, M. D., Gajer, P., Tracy, J. K., Zenilman, J. M., Ravel, J., & Gravitt, P. E. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu330 · Cited by 411
Rodriguez, A. C., Schiffman, M., Herrero, R., Hildesheim, A., Bratti, C., Sherman, M. E., Solomon, D., Guillen, D., Alfaro, M., Morales, J., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq001 · Cited by 383
The known unknowns of HPV natural history
Gravitt, P. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57149 · Cited by 378
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
Garçon, N., & Van Mechelen, M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.29 · Cited by 314
Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer
Chelimo, C., Wouldes, T. A., Cameron, L. D., & Elwood, J. M. (2013) · Journal of Infection · doi:10.1016/j.jinf.2012.10.024 · Cited by 303
Epidemiology and Natural History of Human Papillomavirus Infections in the Female Genital Tract
Ault, K. A. (2006) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/idog/2006/40470 · Cited by 269
Insinga, R. P., Liaw, K.-L., Johnson, L. G., & Madeleine, M. M. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2922 · Cited by 267
Gravitt, P. E., Belinson, J. L., Salmeron, J., & Shah, K. V. (2011) · International Journal of Cancer · doi:10.1002/ijc.25974 · Cited by 106
Datta, P., Bhatla, N., Pandey, R. M., Dar, L., Patro, A. R., Vasisht, S., Kriplani, A., & Singh, N. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.3.1019 · Cited by 31
Amith, M., Lin, R., Cunningham, R., Wu, Q. L., Savas, L. S., Gong, Y., Boom, J. A., Tang, L., & Tao, C. (2020) · arXiv · doi:10.48550/arxiv.2001.02306 · Cited by 14
Metadata
- Authors
- Brown, D. R., Shew, M. L., Qadadri, B., Neptune, N., Vargas, M., Tu, W., Juliar, B. E., Breen, T. E., & Fortenberry, J. D.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-01-15
- Volume
- 191
- Issue
- 2
- Pages
- 182-192
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2154502813
- Cited by
- 418
- References
- 32
- FWCI
- 17.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.